Literature DB >> 3005277

Expression of transferrin receptors in phytohemagglutinin-stimulated human T-lymphocytes. Evidence for a three-step model.

E Pelosi, U Testa, F Louache, P Thomopoulos, G Salvo, P Samoggia, C Peschle.   

Abstract

Resting human T-lymphocytes show an elevated intracellular concentration of ferritin, whereas transferrin receptors are not detectable. Stimulation by phytohemagglutinin markedly lowers their ferritin content, while inducing the synthesis of transferrin receptors. Addition of iron salts (ferric ammonium citrate) in activated T-lymphocyte cultures causes a marked enhancement of both [3H]uridine and [3H]thymidine incorporation. Nevertheless, it also induces a concentration-dependent decrease in transferrin receptor synthesis, associated with a marked rise of ferritin production. Hemin treatment exerts the same effects. Addition of picolinic acid in phytohemagglutinin-stimulated cultures causes a decrease of [3H]thymidine incorporation, whereas transferrin expression is markedly enhanced. The action of iron salts and chelators is specific for transferrin receptors, since the expression of other membrane markers of activated human T-lymphocytes (interleukin-2 receptor, insulin receptor, and HLA-DR antigen) is not modified by treatment with iron or picolinic acid. These observations suggest that expression of transferrin receptors in activated T-lymphocytes is specifically modulated by their intracellular iron level, rather than their proliferative rate. Addition of picolinic acid to resting T-lymphocytes in the absence of mitogen induces a marked decrease of their ferritin content, but not the appearance of transferrin receptors. On the basis of these results, we suggest a three-step model: (a) in resting T-lymphocytes, the gene for transferrin receptor is apparently "closed," in that it is not expressed under both normal conditions and following iron deprivation. (b) After mitogen stimulus, T-lymphocytes are reprogrammed into cell cycle progression, which necessarily entails synthesis of transferrin receptors (c) Expression of these receptors is modulated by the intracellular iron level, rather than the rate of proliferation per se.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005277

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Modulation of ferritin H-chain expression in Friend erythroleukemia cells: transcriptional and translational regulation by hemin.

Authors:  E M Coccia; V Profita; G Fiorucci; G Romeo; E Affabris; U Testa; M W Hentze; A Battistini
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

2.  Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells.

Authors:  J B Trepel; O R Colamonici; K Kelly; G Schwab; R A Watt; E A Sausville; E S Jaffe; L M Neckers
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

Review 3.  Surface antigens associated with human B cell activation.

Authors:  L K Jung
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

4.  Post-transcriptional regulation of transferrin receptor mRNA by IFN gamma.

Authors:  M F Bourgeade; F Silbermann; L Kühn; U Testa; C Peschle; S Mémet; M N Thang; F Besançon
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

5.  Regulation of Cu,Zn superoxide dismutase with copper. Caeruloplasmin maintains levels of functional enzyme activity during differentiation of K562 cells.

Authors:  S S Percival; E D Harris
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

6.  Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.

Authors:  C Giordano; R De Maria; M Todaro; G Stassi; A Mattina; P Richiusa; G Galluzzo; F Pantó; A Galluzzo
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

7.  Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.

Authors:  E Pelosi-Testa; P Samoggia; G Giannella; E Montesoro; T Caravita; G Salvo; A Camagna; G Isacchi; U Testa; C Peschle
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

8.  Two genetic loci participate in the regulation by iron of the gene for the human transferrin receptor.

Authors:  J L Casey; B Di Jeso; K Rao; R D Klausner; J B Harford
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.

Authors:  Elizabeth Townsley; Marcia Woda; Stephen J Thomas; Siripen Kalayanarooj; Robert V Gibbons; Ananda Nisalak; Anon Srikiatkhachorn; Sharone Green; Henry A F Stephens; Alan L Rothman; Anuja Mathew
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

10.  Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.

Authors:  Yuran Xie; Na Hyung Kim; Venkatareddy Nadithe; Dana Schalk; Archana Thakur; Ayşe Kılıç; Lawrence G Lum; David J P Bassett; Olivia M Merkel
Journal:  J Control Release       Date:  2016-03-19       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.